Methods and results of locoregional treatment of brain metastases in patients with non-small cell lung cancer.
Contemp Oncol (Pozn)
; 20(5): 358-364, 2016.
Article
en En
| MEDLINE
| ID: mdl-28373816
ABSTRACT
This article presents methods and results of surgery and radiotherapy of brain metastases from non-small cell lung cancer (BMF-NSCLC). Patients with single BMF-NSCLC, with Karnofsky score ≥ 70 and controlled extracranial disease are the best candidates for surgery. Stereotactic radiosurgery (SRS) is recommended in patients with 1-3 BMF-NSCLC below 3-3.5 cm, with minor neurological symptoms, located in parts of the brain not accessible to surgery, with controlled extracranial disease. Whole brain radiotherapy (WBRT) following SRS reduces the risk of local relapse; in selected patients median survival reaches more than 10 months. Whole brain radiotherapy alone is a treatment in patients with multiple metastases, poor performance status, uncontrolled extracranial disease, disqualified from surgery or SRS with median survival 3 to 6 months. There is no doubt that there are patients with BMF-NSCLC who should receive only the best supportive care. There is a debate in the literature on how to select these patients.
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Contemp Oncol (Pozn)
Año:
2016
Tipo del documento:
Article